Trends in Genetics
Volume 36, Issue 7, July 2020, Pages 499-509
Journal home page for Trends in Genetics

Review
Using Genetic and Species Diversity to Tackle Kidney Disease

https://doi.org/10.1016/j.tig.2020.04.001Get rights and content

Highlights

  • Exploring the large diversity of genetic backgrounds in mice and rats can improve modeling of kidney disease.

  • The Diversity Outbred (DO) mouse and Heterogeneous Stock (HS) rat populations display high genetic and phenotypic variability and enable precise genetic mapping of complex genetic traits, such as kidney disease.

  • Taking advantage of the genetic tools and natural occurring systems in species such as zebrafish, Drosophila, cats, and bears can provide more insight into the role of genes in the kidney.

Progress in the identification of causal genes and understanding of the mechanism underlying kidney disease is hindered by the almost exclusive use of a few animal models with restrictive monogenic backgrounds that may be more resistant to kidney disease compared with humans and, therefore, poor models. Exploring the large genetic diversity in classical animal models, such as mice and rats, and leveraging species diversity will allow us to use the genetic advantages of zebrafish, Drosophila, and other species, to develop both new animal models that are more relevant to the study of human kidney disease and potential therapies.

Section snippets

The Need for Animal Models to Study Kidney Disease

The past two decades have seen a tremendous gain in tools and approaches to study the genetic basis of kidney disease in humans. Genetics studies have moved from investigating genetic variation in single genes (i.e., candidate gene approach) using small populations (50–500 subjects) to large-scale genetic studies [genome-wide association study (GWAS); see Glossary] involving the assay of millions of SNPs by microarray, exome sequencing, and even whole-genome sequencing in populations of several

The Mouse as a Model for Kidney Disease

The mouse has been an important model in biomedical research for more than a century. The most widely studied inbred strain is C57BL/6 (B6), developed in 1918 by Clarence Cook Little, which has been used almost exclusively in kidney research. This is mainly because: the strain breeds well and is easy to maintain; there is a vast knowledge on this strain because it has been used by many investigators in the past 100 years; it is one of the few strains that allows for genetic manipulation using

The Rat as a Model for Kidney Disease

Several inbred rat genetic models exhibiting a robust kidney disease phenotype, including the development of overt proteinuria, decline in renal function, and significant histological damage (glomerulosclerosis, tubulointerstial injury/fibrosis, and vascular hypertrophy), are available [15]. For example, there are several hypertensive models, such as the stroke-prone spontaneously hypertensive rat (SHRSP) [16], Dahl salt-sensitive (DSS) [17,18], Fawn-hooded hypertensive rat (FHH) [19,20], and

Using Genetic Diversity in Rodents to Identify Candidate Genes

Both mice and rats are excellent models to study a complex genetic trait, such as kidney disease, and identify the underlying genetic factors. Given that environmental factors, such as diet and the microbiome, can be controlled, the number of individuals needed to have the same power of detection is smaller compared with humans. Over the past few decades, several genetic studies using crosses between inbred strains have been performed in mice and rats, and we have reviewed these previously [30

The Advantages of the Zebrafish

In addition to the common rodent models, there are several other animal models that are useful to study kidney disease. The zebrafish embryonic kidney (pronephros) shows histological and functional similarities to the mammalian adult nephron. This, combined with rapid ex utero development, transparent embryos, high fecundity, a well-characterized genome, and tools for gene editing, has led to an exponential growth in the number of zebrafish models to study kidney disease. Several excellent

Drosophila as an Emerging Model

Drosophila has a highly specialized filtration structure called the nephrocyte diaphragm, which shares similarities to the slit diaphragm structure of the mammalian glomerular podocyte [59]. Zhe Han developed Drosophila as a model to study podocyte biology and for large-scale genetic screens to identify and study novel genes that are involved in podocyte function and renal diseases. Similar to the experiment with Shroom3 in zebrafish, rescue of renal phenotypes in Drosophila with alleles from

Unconventional Animal Models

There have been some studies that suggest felids, including tigers, leopards, lions, cheetahs, and cougars, could provide interesting insights into the pathophysiology of CKD. For example, a study of 38 deceased captive wild felids originating from eight German zoological gardens found that 33 animals or 87% demonstrated significant renal lesions [62]. In >50% of these animals, significant tubular changes, including tubular epithelial degeneration, necrosis, and proteinaceous casts, were

Concluding Remarks and Future Perspectives

Despite the tremendous advances in human genetic studies, there is still a great need for animal models to study and better understand kidney disease and the genetic factors that are involved. The almost exclusive use of a few species (mouse and rat) with restricted genetic backgrounds (e.g., mostly C57BL/6 mice) has limited these studies and contributed to the reputation that animal models are limited and do not reflect the human condition. Exploring the large genetic variation in rodent

Acknowledgments

This work was supported by grants from the National Institutes of Health (R01 HL137673 to M.R.G. and P30 AG038070, U54 OD020351, and RO1 ES029916 to R.K.).

Glossary

Albuminuria/proteinuria
presence of albumin or protein in the urine, which is an indicator of renal damage.
Blood urea nitrogen (BUN)
elevated BUN is indicative of reduced renal function.
CRE recombinase
enzyme that catalyzes the site-specific recombination of DNA between loxP sites (see ‘Floxed genes’)
CRISPR/Cas9
a genome-editing system based on the ability of the Cas9 enzyme to cut DNA at a specific sequence as directed by a guide RNA sequence.
Estimated glomerular filtration rate (eGFR)
used in

References (71)

  • M. Gorski

    1000 Genomes-based meta-analysis identifies 10 novel loci for kidney function

    Sci. Rep.

    (2017)
  • T. de Groot

    Identification of Acer2 as a first susceptibility gene for lithium-induced nephrogenic diabetes insipidus in mice

    J. Am. Soc. Nephrol.

    (2019)
  • K. Azushima

    Modelling diabetic nephropathy in mice

    Nat. Rev. Nephrol.

    (2018)
  • X. Wu

    Genetic modulation of diabetic nephropathy among mouse strains with Ins2 Akita mutation

    Physiol. Rep.

    (2014)
  • D. Cosgrove

    Collagen COL4A3 knockout: a mouse model for autosomal Alport syndrome

    Genes Dev.

    (1996)
  • M.N. Rheault

    Mouse model of X-linked Alport syndrome

    JASN

    (2004)
  • R. Schmitt

    Ageing mouse kidney--not always the SAME old story

    Nephrol. Dial. Transplant.

    (2009)
  • N.O. Lindström

    Conserved and divergent features of human and mouse kidney organogenesis

    J. Am. Soc. Nephrol.

    (2018)
  • A. Schulz et al.

    Mapping genetic determinants of kidney damage in rat models

    Hypertens. Res.

    (2012)
  • T. Kato

    Blood pressure, renal biochemical parameters and histopathology in an original rat model of essential hypertension (SHRSP/Kpo strain)

    Biomed. Res.

    (2015)
  • J.P. Rapp et al.

    Development and characteristics of inbred strains of Dahl salt-sensitive and salt-resistant rats

    Hypertension

    (1985)
  • M.R. Garrett

    Time-course genetic analysis of albuminuria in Dahl salt-sensitive rats on low-salt diet

    JASN

    (2003)
  • M.H. Kuijpers et al.

    Spontaneous hypertension in the fawn-hooded rat: a cardiovascular disease model

    J. Hypertens. Suppl.

    (1986)
  • M.H. de Keijzer

    Proteinuria is an early marker in the development of progressive renal failure in hypertensive fawn-hooded rats

    J. Hypertens.

    (1989)
  • C. Yagil

    Proteinuria and glomerulosclerosis in the Sabra genetic rat model of salt susceptibility

    Physiol. Genomics

    (2002)
  • P.A. Doris

    Genetics of hypertension: an assessment of progress in the spontaneously hypertensive rat

    Physiol. Genomics

    (2017)
  • I.S. Dhande

    Stim1 polymorphism disrupts immune signaling and creates renal injury in hypertension

    J. Am. Heart Assoc.

    (2020)
  • M.L. Gonzalez-Garay

    Diversity in the preimmune immunoglobulin repertoire of SHR lines susceptible and resistant to end-organ injury

    Genes Immun.

    (2014)
  • A. Brandis

    Age-dependent glomerulosclerosis and proteinuria occurring in rats of the Milan normotensive strain and not in rats of the Milan hypertensive strain

    Lab. Investig.

    (1986)
  • K. Kawano

    Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain

    Diabetes

    (1992)
  • O. Palygin

    Progression of diabetic kidney disease in T2DN rats

    Am. J. Physiol. Renal Physiol.

    (2019)
  • M.A. Nobrega

    Initial characterization of a rat model of diabetic nephropathy

    Diabetes

    (2004)
  • M.R. Garrett

    Integrating human and rodent data to identify the genetic factors involved in chronic kidney disease

    J. Am. Soc. Nephrol.

    (2010)
  • J.M. Williams

    Genetic variants in Arhgef11 are associated with kidney injury in the Dahl salt-sensitive rat

    Hypertension

    (2012)
  • A.C. Johnson

    Loss of Arhgef11 in the Dahl salt-sensitive rat protects against hypertension-induced renal injury

    Hypertension

    (2020)
  • Cited by (9)

    • Zebrafish as a powerful alternative model organism for preclinical investigation of nanomedicines

      2022, Drug Discovery Today
      Citation Excerpt :

      In this regard, zebrafish have received much attention for preclinical evaluation of nanomedicines because of their ability to screen these formulations quickly under in vivo conditions in an economical manner thus reducing disparities between in vitro and in vivo rodent studies. Several crucial attributes of zebrafish such as high fecundity (up to hundreds of eggs per day), low husbandry costs (as compared with rodents), well-characterized developmental stages, small size of embryos and larvae (0.5–5.0 mm depending on the stage of development), high level of genetic homology to humans (∼70%), rapid ex utero development, availability of transgenic lines and, most strikingly, optical transparency make this a promising model for preclinical investigation of nanomedicines (Fig. 1).12–15 The optical transparency of zebrafish larvae can be lengthened to several days either chemically (viz. by using 1-phenyl-2-thiourea) to suppress melanogenesis16 or using genetic manipulation (such as casper/crystal mutant).17

    • Multidisciplinary approaches for elucidating genetics and molecular pathogenesis of urinary tract malformations

      2022, Kidney International
      Citation Excerpt :

      The zebrafish pronephros is formed by 4 days post fertilization (dpf) and can be visualized by either whole-mount immunostaining or with transgenic lines that elaborate kidney structures with fluorescent proteins driven by kidney-specific promoters.125 Importantly, zebrafish larvae display cell-type similarity and structural resemblance of pronephric components with the mammalian glomerulus and proximal convoluted tubule (Figure 2a–c).122,125–127 Lower urinary tract structures are absent in zebrafish; however, surrogates in the distal anatomic regions can be used to model anomalies of the ureters, bladder, or urethra.

    View all citing articles on Scopus
    View full text